Details of the Drug

General Information of Drug (ID: DMXFZZB)

• Drug Name: Tofogliflozin
• Synonyms: TOFOGLIFLOZIN; 903565-83-3; CSG 452; Tofogliflozin anhydrous; UNII-554245W62T; CSG-452; 554245W62T; deberza; apleway; Tofogliflozin [INN]; R-7201; Tofogliflozin anyhydrous; Tube107; EC 619-989-0; SCHEMBL903156; GTPL9395; CHEMBL2110731; DTXSID90238097; CSG452;CSG-452; CHEBI:136041; MolPort-044-723-920; ZINC35826342; BDBM50396779; AKOS027250822; DB11824; SB11170; compound 16d [PMID: 22889351]; NCGC00485920-01; KB-76204

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Approved	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C22H26O6
  Canonical SMILES: CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2
  InChI: InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1
  InChIKey: VWVKUNOPTJGDOB-BDHVOXNPSA-N
• Cross-matching ID:
  PubChem CID: 46908929
  ChEBI ID: CHEMBL2110731
  CAS Number: 903565-83-3
  UNII: 554245W62T
  DrugBank ID: DB11824
  TTD ID: D04DXA
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Tofogliflozin: first global approval. Drugs. 2014 Jun;74(8):939-44.